[HTML][HTML] Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation
LJH Rasmussen, JEV Petersen… - Frontiers in …, 2021 - frontiersin.org
Systemic chronic inflammation (SCI) is persistent, health-damaging, low-grade inflammation
that plays a major role in immunosenescence and in development and progression of many …
that plays a major role in immunosenescence and in development and progression of many …
Recent advancements of nanomodified electrodes–Towards point-of-care detection of cardiac biomarkers
The increasing number of deaths from cardiovascular diseases has become a substantial
concern in both developed and underdeveloped countries. Rapid and on-site monitoring of …
concern in both developed and underdeveloped countries. Rapid and on-site monitoring of …
[HTML][HTML] Soluble urokinase receptor (SuPAR) in COVID-19–related AKI
Background AKI commonly occurs in patients with coronavirus disease 2019 (COVID-19). Its
pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the …
pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the …
[HTML][HTML] Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
People with kidney disease are disproportionately affected by atherosclerosis for unclear
reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived …
reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived …
Independent impact of periodontitis and cardiovascular disease on elevated soluble urokinase‐type plasminogen activator receptor (suPAR) levels
Background Previous studies have demonstrated that a soluble urokinase‐type
plasminogen activator receptor (suPAR) plays an essential function in leukocytes and …
plasminogen activator receptor (suPAR) plays an essential function in leukocytes and …
[PDF][PDF] Statins and C-reactive protein: in silico evidence on direct interaction
N Shakour, M Ruscica, F Hadizadeh, C Cirtori… - Archives of Medical …, 2020 - termedia.pl
Results Docking experiments showed that all statins could directly interact with CRP. Among
statins, rosuvastatin had the strongest interaction with CRP (pKi= 16.14), followed by …
statins, rosuvastatin had the strongest interaction with CRP (pKi= 16.14), followed by …
[HTML][HTML] A systematic review and meta-analysis of advanced biomarkers for predicting incident cardiovascular disease among asymptomatic middle-aged adults
JL Romero-Cabrera, J Ankeny… - International Journal of …, 2022 - mdpi.com
Cardiovascular disease (CVD) continues as the most important cause of mortality. Better risk
screening and prediction are needed to reduce the cardiovascular disease burden. The aim …
screening and prediction are needed to reduce the cardiovascular disease burden. The aim …
[HTML][HTML] Effect of dietary inflammatory potential on the aging acceleration for cardiometabolic disease: A population-based study
Y Hu, X Wang, J Huan, L Zhang, L Lin, Y Li, Y Li - Frontiers in nutrition, 2022 - frontiersin.org
Background/Aim Optimized dietary patterns have been considered an important determinant
of delaying aging in cardiometabolic disease (CMD). Dietary pattern with high-level dietary …
of delaying aging in cardiometabolic disease (CMD). Dietary pattern with high-level dietary …
[HTML][HTML] Subclinical doxorubicin-induced cardiotoxicity update: role of neutrophils and endothelium
VK Todorova, JY Wei, I Makhoul - American Journal of Cancer …, 2021 - ncbi.nlm.nih.gov
Doxorubicin (DOX) is a highly effective chemotherapy agent that often causes cardiotoxicity.
Despite a number of extensive studies, the risk for DOX cardiotoxicity remains unpredictable …
Despite a number of extensive studies, the risk for DOX cardiotoxicity remains unpredictable …
Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
Cardiovascular disease (CVD) is an inflammatory disease that different factors play a crucial
role in the development of clinical outcome of this disease. Inflammation could have effects …
role in the development of clinical outcome of this disease. Inflammation could have effects …